В портфеле редакции

Studies on sport mega-events and their legacies often seem only loosely connected to local experiences. Stories on sport mega-event legacy appear as a setting-the-scene or function as a reference to illustrate specific types of legacy. However, stories themselves are never the primary focus in these studies. What is generally lacking from these studies is an interpretive perspective, giving voice to ordinary citizens’ everyday experiences of legacies in mundane aspects of their lives and their local environment. The article aims to add an analysis of stories to the existing body of knowledge as an innovative way of interpreting sport mega-events’ legacies. We introduce a narrative ethnographic approach for studying sport mega-event legacy, by looking at the way stories and narrative analysis are used to conceptualise legacy in the sociological subfield of ageing-studies. In our case study we show how citizens from one Johannesburg township make sense of the legacy of the 2010 FIFA World Cup one year after the event, by analysing people's stories about two sport-for-development projects. We conclude that local residents of the township of Alexandra perceive changes in public safety and the image of Alexandra as the most important positive legacy of the 2010 FIFA World Cup. At the same time they take a critical stance towards the World Cup's legacy, because personal situations and community structures were often disrupted, rather than improved. We maintain that a narrative ethnographic approach provides extensive accounts about sport mega-event legacies, which help to better understand the different faces of sport mega-events’ legacies at a micro level

Current and Future Incidence and Costs of Osteoporosis-Related Fractures in the Netherlands

This study aims to estimate the incidence and costs of osteoporosis-related fractures in The Netherlands in 2010 and project them to 2030. The incidence and costs of five different types of fractures (spine, hip, upper extremity, lower extremity, wrist/distal forearm, other) were derived from claims data of all Dutch healthcare insurers. Given that fracture-codes in claims data do not indicate whether fractures are related to osteoporosis, we used a large dataset with DXA measurements to attribute fractures to osteoporosis. Future projections used four scenarios: (1) demographic, (2) demographic ? annual trend in incidence rates, (3) demographic ? annual trend in incidence rates ? annual trend in costs, and (4) treatment. Of all registered fractures, 32 % was attributed to osteoporosis (36 % in women and 21 % in men). Over time (2010–2030) the increase in incidence of osteoporosis-related fractures was estimated to be 40 % (scenario 1); for the hip 60–79 % (scenario 1–2). In 2010, approximately €200 million was spent on treatment of osteoporosis-related fractures, most on fractures of the hip followed by wrist/distal forearm. In both men and women, the excess costs due to osteoporosis-related fractures were highest for hip fractures (€11,000–€13,000 per person), followed by spine fractures (€6000–€7000).The costs for osteoporosisrelated fractures were projected to increase with 50 % from 2010 to 2030 (scenario 1); for the hip 60–148 % (scenario 1–3). Pharmacotherapeutic prevention can lead to costsavings of €377 million in 2030 (scenario 1 and 4 combined). The projected increase in incidence and costs of osteoporosis-related fractures calls for a wider use of prevention and treatment

Should we screen for coronary artery disease in asymptomatic chronic dialysis patients?

The hemodialysis population is characterized by a high prevalence of ‘asymptomatic’ coronary artery disease (CAD), which should be interpreted differently from asymptomatic disease in the general population. A hemodynamically significant stenosis may not become clinically apparent owing to impaired exercise tolerance and autonomic neuropathy. The continuous presence of silent ischemia may cause heart failure, arrhythmias, and sudden death. Whether revascularization of an asymptomatic dialysis patient improves outcome remains a moot point, although several observational studies and one small RCT suggest a benefit. It can therefore be defended to screen asymptomatic dialysis patients for CAD. A number of noninvasive screening tests are available, but none has proved equally practical and reliable in the dialysis population as in the general population. Myocardial perfusion scintigraphy (MPS) before and after a pharmacological stress such as dipyridamole can reveal both ischemia and myocardial scarring. When compared with coronary angiography, low sensitivities were reported and attributed to impaired vasodilation to dipyridamole in dialysis patients. A more likely explanation is that not every anatomical stenosis will lead to impaired coronary blood flow on MPS. Numerous studies have shown an incremental prognostic value of dipyridamole-MPS over clinical data for prediction of adverse cardiac events, in some studies even over coronary angiography. Pending the availability of high-quality evidence, in our opinion asymptomatic dialysis patients could undergo dipyridamole-MPS, followed by coronary angiography in case of an abnormal scan. This combined physiological and anatomical evaluation of the coronary circulation allows us to determine which coronary stenosis is clinically relevant and therefore should be revascularized

The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom:Population-Based Cohort Study

OBJECTIVES: Bisphosphonates (BPs) might have extra benefits in reducing mortality because of their anti-atherosclerotic effects, but studies reported conflicting results. We investigated the association between oral BP use and mortality risk following a major osteoporotic fracture (MOF) in the United Kingdom. DESIGN: This was a population-based cohort study. SETTING AND PARTICIPANTS: In total, 163,273 adults aged 50 years and older with an MOF between 2000 and 2018 from the Clinical Practice Research Datalink in the United Kingdom. METHODS: Cox proportional hazards models were used to estimate the risk of all-cause mortality in current (0‒6 months), recent (7‒12 months), and past (>1 year) exposures to oral BPs after nonhip MOF and hip fracture. In addition, stratification by sex, BP type, and duration of follow-up was performed. RESULTS: Compared with never users of oral BPs, current BP use was associated with a 7% higher all-cause mortality risk after nonhip MOF, whereas a 28% lower all-cause mortality risk was observed after hip fracture. Past BP exposure was associated with a 14% and 42% lower risk after nonhip MOF and hip fracture, respectively. When considering only the first 5 years of follow-up, mortality risk associated with current BP use was significantly lower for both fracture groups, and the greatest reduction in mortality risk was observed within the first year. Women had slightly lower risk compared with men. CONCLUSIONS AND IMPLICATIONS: We found a slight increased risk of all-cause mortality with current BP exposure after a nonhip MOF; however, a protective effect was observed following a hip fracture. Both the timing and the effect size of an association based on the anti-atherosclerotic hypothesis of BPs are not supported by our results. The decreasing trend of the mortality risk with shorter durations of follow-up suggests that the observed association is likely due to unknown distortion or unknown pleiotropic properties of BPs

Blow up dynamics for smooth equivariant solutions to the energy critical Schr\"odinger map

We consider the energy critical Schr\"odinger map problem with the 2-sphere target for equivariant initial data of homotopy index $k=1$. We show the existence of a codimension one set of smooth well localized initial data arbitrarily close to the ground state harmonic map in the energy critical norm, which generates finite time blow up solutions. We give a sharp description of the corresponding singularity formation which occurs by concentration of a universal bubble of energy

Total VOC reactivity in the planetary boundary layer: 2. A new indicator for determining the sensitivity of the ozone production to VOC and NO

A new indicator is proposed for determining if tropospheric ozone production in a specifiacr eai s limitedb yV OC or NOx.T he indicato1r 9= r•ø•C/•oød•Xes cribeths e ratio of the lifetimes of OH against the losses by reacting with VOC and NOx. Whereas •oøx• c anb e obtainebdy c onventionmale asurementthse, n ewp umpa ndp robeO H approach which is described in part one of this publication makes it now possible to obtain also ß_ov •o c ßI ndicator values above a thresholdv alue of 0.2 __+50 % are representativeo f NOx-saturatedc onditionsw here an increaseo f NOx emissionsc auses lower ozone production.F or valuesb elow 0.01 the ozone productioni s very insensitivet o changeso f VOC emissionsT. he robustnesso f this indicator againsts everalp arameters sucha s temperature,h umidity,p hotolysisa, nd initial ozone concentrationsis tested in a box model and comparedt o the robustnesso f other earlier proposedi ndicators.I n contrast to earlier proposed indicators, this new one is not based on photochemically producedl ong-liveds peciesb ut describest he instantaneousr egime of an air parcel. Three-dimensionasl imulations howst hat this indicator is quite successfuiln estimatingt he impact of increasedo r reducede missionso n the ozone concentrationsfo r each location in the modeling area. This will make it a very helpful tool for developing ozone abatement strategies

Usage of TCRAV and TCRBV gene families in human fetal and adult TCR rearrangements

We have investigated fetal and adult T-cell receptor (TCR) A and B V-gene repertoires both by fluorescence-activated cell sorter (FACS) analysis with the avialable TCR V region-specific mAbs and by the polymerase chain reaction (PRC) with TRC V gene family-specific oligonucleotides. Among the low number of CD3+ T cells, most of the TRC V region tested for could be detected by FACS analysis in liver, bone marrow, and spleen derived from a 14-week-old fetus and two 15-weeks-old fetuses. Similarly, the PCR analysis showed that the majority of the TCRAV and TCRBV families were expressed in the peripheral organs of the 13-week-old fetus, although an apparent absence of particular TCR V families was found in liver and bone marrow. This was most probably the consequence of the low number of CD3+ T cells in these organs. In 17-week-old week-old fetal thymi the level of expression of some TCRAV and TCRBV gene families, in particular those that contain single member, was lower compared to post-partum thymi and adult peripheral blood mononuclear cells. The combined data of FACS and PCR analysis demonstrate that TCR genes belonging to the majority of TCR V gene families can be used in TCR α and β chain rearrngements during early human fetal life. Our data also suggest that the expression levels of some of the single member TCR V gene families may be influenced by the development stage

Paul Eelen : reflections on life and work

This manuscript is part of a special issue to commemorate professor Paul Eelen, who passed away on August 21, 2016. Paul was a clinically oriented scientist, for whom learning principles (Pavlovian or operant) were more than salivary responses and lever presses. His expertise in learning psychology and his enthusiasm to translate this knowledge to clinical practice inspired many inside and outside academia. Several of his original writings were in the Dutch language. Instead of editing a special issue with contributions of colleagues and friends, we decided to translate a selection of his manuscripts to English to allow wide access to his original insights and opinions. Even though the manuscripts were written more than two decades ago, their content is surprisingly contemporary. This introductory article presents a reflection on Paul’s career and legacy and introduces the selected manuscripts that are part of this special issue